Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
Felix Boria AlegreLuis ChivaVanna ZanagnoloDenis QuerleuNerea Martin-CalvoMihai Emil CăpîlnaAnna FagottiAli KucukmetinConstantijne MomGalina ChakalovaAliyev ShamistanMario MalzoniFabrice NarducciOctavio ArencibiaFrancesco RaspagliesiTayfun ToptasDavid CibulaDilyara KaidarovaMehmet Mutlu MeydanlıMariana TavaresDmytro GolubAnna Myriam PerroneRóbert PókaDimitrios TsolakidisGoran VujićMarcin A JedrykaPetra L M ZusterzeelJogchum Jan BeltmanFrederic GoffinDimitrios HaidopoulosHerman HallerRobert JachIryna YezhovaIgor BerlevMargarida BernardinoRasiah BharathanMaximilian LannerMinna M MaenpaaVladyslav SukhinJean-Guillaume FeronRobert FruscioKersti KukkJordi PonceMaría Alonso-EspíasJose Angel MinguezDaniel Vázquez-VicenteNabil ManzourMatias JuradoTeresa CastellanosEnrique ChacónJuan Luis AlcazarPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
In this European cohort, the rate of adjuvant therapy after radical hysterectomy is higher than for most similar patients reported in the literature. The majority of centers were already following the European recommendations even 5 years prior to the ESGO quality indicator implementations.